LacerationsNCT03830515
Evaluation of microMend Device to Close Lacerations
A study testing microMend in people with Lacerations and Wounds, run by KitoTech Medical, Inc. at 1 site in United States.
Trial summary
In this study, total of 20 subjects will have lacerations will be closed with microMend, which is an FDA-listed wound closure product. microMend is a wound closure device that is the size and shape of a butterfly bandage and incorporates tiny Microstaples into an adhesive backing. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Lacerations, Wounds
- What is being tested?
- microMend
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteUnited States
- Study dates
- 20 Apr 2018to 31 Dec 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Subjects undergoing a laceration repair that would require sutures, staples, or tissue adhesives to close the skin wound
- Age equal to or greater than 18 years old
- Written informed consent obtained from Subject or Subject's legal representative and ability for Subject to comply with the requirements of the Study
Who cannot join
- Wound on face
- Wound on flexor surfaces such as over joints
- Wound on digits (fingers or toes)
- Wound under high tension, which is not closed with subcutaneous sutures before application of microMend devices
- Wound that has a gap of more than 1 cm between the wound edges immediately prior to application of microMend devices
- Wound with jagged or irregular edges
Show all 23Show fewer
- Wound with significant tissue injury
- Visual evidence of active infection, contaminated or devitalized tissue, or rash at laceration location
- Wound that contain a foreign body
- Wound site that contains tattoo or other identifiable features
- Subject with keloid(s)
- Medical disorder that, in the opinion of the Provider, could have a significant effect on wound healing
- Pregnancy
- Inability of Subject to carry out Subject instructions
- Subject lacks the capacity to consent
- Medication that, in the opinion of the Provider, could have a significant effect on wound healing
- Skin disorder, such as psoriasis, or current dermatitis or eczema at wound site
- History of keloids or scar hypertrophy
- Known bleeding diathesis
- Sensitivity or allergy to adhesives or medical tape
- Active infection in any part of the body
- Use of sutures or staples in addition to microMend to close the outermost skin layer
- Use of tissue adhesive or other adhesives directly over the wound
Trial locations and contacts
1 site in 1 country.
United States1 site, 1 recruiting
- Recruiting
Rhode Island Hospital
Providence, Rhode Island, 02903
Francesca Beaudoin, MD, PhD
About this study
Official title: Evaluation of microMend Device to Close Skin Wounds Associated With Repair of Lacerations
In this study, total of 20 subjects will have lacerations will be closed with microMend, which is an FDA-listed wound closure product. microMend is a wound closure device that is the size and shape of a butterfly bandage and incorporates tiny Microstaples into an adhesive backing. Assessments by practitioners and Subjects of microMend will be made at Days 0 10, and 3 months using a combination of questionnaires and photographs.
Read the detailed description
This is an open-label, single-arm Phase 2 Study to evaluate closure of skin wounds associated with laceration repair using microMend devices. A maximum of 20 Subjects will be enrolled in the Study in order to have 15 Subjects with evaluations at Month 3 after wound closure. The primary intent is to assess the wound closure results with microMend closure at Month 3 after the wound closure procedure. Evaluations will also take place at Days 0 and 10 and 1 Month post-procedure to assess wound closure results. An Independent Plastic Surgeon who is not closing wounds in the study will assess the efficacy of wound closure at Day 10, Month 1, and Month 3. Assessment will also be made of the Subject's pain with applying microMend, time of wound closure, and opinions of the Providers and Subjects about microMend.
Screening data will be reviewed to determine Subject eligibility. Subjects who meet all inclusion criteria and none of the exclusion criteria will be entered into the Study. The Provider may elect to close additional wounds in subjects who have more than one wound that qualifies for the study.
In the Study, eligible Subjects will undergo the laceration repair procedure as is standard and customary for each Provider except for skin closure will be performed using microMend devices. If more than one device is needed, the devices are to be applied adjacent to one another along the entire length of the wound. microMend devices are to be applied immediately adjacent to one another with no more than 1 mm separating each adjacent device. (Note: Each device closes 1-1.5 cm of wound length.). In addition, devices should be applied such that they extend to or beyond the ends of the wound along its length.
A minimum of two (2) photographs will be taken of each wound both before and after the application of microMend devices on the day of the wound closure procedure (Day 0).
If a wound is under high tension and/or has a maximum gap of more than 1 cm between the wound edges, it should be closed with subcutaneous sutures before applying microMend devices. If this is not performed, the wound should not be closed with microMend and the Subject is not eligible for the study.
Standard surgical staples, sutures, tissue adhesives, SteriStrips or other bandages should not be used to close any portion of skin wounds closed with microMend devices.
Each wound should be free of significant tissue injury and bleeding, contain no foreign bodies, and should be clean and completely dry and free of hair before application of microMend.
No other wound closure products, such as tissue adhesives, bandages such as SteriStrips, staples, or sutures should be applied to the wound.
Solutions, ointments, creams, and other moist materials should be avoided during the time period when the microMend remains on the skin except those recommended by the Provider.
After application of the microMend devices, it is recommended that each wound be covered with a non-stick gauze dressing. (Note: contact of adhesive with microMend devices is strictly prohibited.) Subject contact with the wound site should be minimized after placement of the microMend devices and the dressing. All other activities associated with the laceration repair procedure should follow the standard procedure used by the Provider. The Provider will fill out a questionnaire about the wound closure procedure. The Subject will rate the level of pain associated with microMend application.
The microMend devices are to be removed at the return clinic visit on Day 10 (acceptable range: Days 7-12) by the Provider (Physician, Nurse Practitioner, Physician's Assistant, or other qualified health care provider). Photographs are to be obtained of each wound both before and after removal of all microMend devices. A minimum of two (2) photographs will be taken of each wound both before and after removal of microMend devices. The Subject will fill out a questionnaire providing an opinion of microMend.
Each Subject is to return to the clinic at one (1) month post-procedure (acceptable range: Days 25-40) to obtain photographs of each wound. A minimum of two (2) photographs will be taken at the 1-month clinic visit. Each Subject is to return to the clinic at three (3) months after wound closure (acceptable range: 11-15 weeks) to obtain photographs of each wound. A minimum of two (2) photographs will be taken at the 1-month clinic visit.
Photographs obtained on Day 0, Day 10, Month 1, and Month 3 will be assessed for wound closure results by an Independent Plastic Surgeon, who is not performing laceration repair or wound closure in the study. The wound closure will be rated as either Satisfactory or Unsatisfactory. The quality of the wound closure will further be rated as Excellent, Good, Fair, or Poor. For Subjects that have had more than one wound closed with microMend devices, each wound is to be assessed separately at Day 0, Day 10, Month 1, and Month 3.
Total duration of Subject participation will be approximately 4 months, including screening, treatment, and follow-up.
- Conditions
- Lacerations, Wounds
- Being tested
- microMend
- Keywords
- Lacerations, Wounds
- Medical subject headings
- Lacerations, Wounds and Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
microMendDevice
Also called microMend Skin Closure Device
Wound closure product consisting of tan array of tiny metal Microstaples affixed to adhesive backing. The device is the size and shape of a butterfly closure and intended for closure of skin wounds.
| Study group | Role | What they receive |
|---|---|---|
| Closure of lacerations with microMend | Experimental | Laceration closure with microMend Receives: Device: microMend |
What is being measured
The primary outcome is the main question the study is designed to answer.
Wound closure results of skin wounds after healing
Assessment of photographs of wounds closed with microMend at Monthg 3 by independent physician with experience in assessing skin wounds.
Measured: 3 months
Overall assessment of microMend by Provider at end of the wound closure procedure.
Questionnaire on opinion of Provider (Physician, PA, or Nurse Practitioner on usability and other characteristics of microMend
Measured: Day 0
Time of wound closure.
Measurement of time in seconds to close wound with microMend devices.
Measured: ay 0
Subject's assessment of microMend.
Measurement of pain upon placement of microMend using VAS scoring system
Measured: Day 0
Subject's assessment of pain with application of microMend
Questionnaire regarding evaluation of microMend
Measured: Day 10
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Feb 2019
- Study start20 Apr 2018
- Primary completion31 Oct 2019 (estimated)
- Study completion31 Dec 2019 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for LacerationsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- A single arm open label study testing the ability of microMend to close lacerations.
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- KitoTech Medical, Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Brown University
- Responsible party
- Sponsor
- Investigators
- Francesca Beaudoin, MD, PhD, Principal investigator, Department of Emergency Medicine, Walpert School of Medicine, Brown UniversityGregory Jay, MD, PhD, Principal investigator, Department of Emergency Medicine, Walpert School of Medicine, Brown University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03830515
- Sponsor's protocol ID
- KTM005
- Status last verified
- Feb 2019
- First submitted
- 2 Feb 2019
- Last updated
- 5 Feb 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Publications
Nizami T, Beaudoin F, Suner S, Aluisio A, Bhatt RA, Jay GD. Evaluation of microMend wound closure device in repairing skin lacerations. Emerg Med J. 2023 Aug;40(8):564-568. doi: 10.1136/emermed-2022-212667. Epub 2023 May 23.
PubMed 37220958
Study at a glance
From the registry record, last updated by the sponsor on 5 Feb 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of microMend Device to Close Skin Wounds Associated With Repair of Lacerations
- ClinicalTrials.gov ID
- NCT03830515
- Acronym / sponsor ID
- KTM005
- Conditions
- Lacerations, Wounds
- Keywords
- Lacerations, Wounds
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- KitoTech Medical, Inc.Industry (pharma, biotech, devices)
- Collaborators
- Brown University
- Study start
- 20 Apr 2018 (actual)
- Primary completion
- 31 Oct 2019 (estimated)
- Study completion
- 31 Dec 2019 (estimated)
- First posted
- 5 Feb 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this study, total of 20 subjects will have lacerations will be closed with microMend, which is an FDA-listed wound closure product. microMend is a wound closure device that is the size and shape of a butterfly bandage and incorporates tiny Microstaples into an adhesive backing. Assessments by practitioners and Subjects of microMend will be made at Days 0 10, and 3 months using a combination of questionnaires and photographs.
Detailed description
This is an open-label, single-arm Phase 2 Study to evaluate closure of skin wounds associated with laceration repair using microMend devices. A maximum of 20 Subjects will be enrolled in the Study in order to have 15 Subjects with evaluations at Month 3 after wound closure. The primary intent is to assess the wound closure results with microMend closure at Month 3 after the wound closure procedure. Evaluations will also take place at Days 0 and 10 and 1 Month post-procedure to assess wound closure results. An Independent Plastic Surgeon who is not closing wounds in the study will assess the efficacy of wound closure at Day 10, Month 1, and Month 3. Assessment will also be made of the Subject's pain with applying microMend, time of wound closure, and opinions of the Providers and Subjects about microMend.
Screening data will be reviewed to determine Subject eligibility. Subjects who meet all inclusion criteria and none of the exclusion criteria will be entered into the Study. The Provider may elect to close additional wounds in subjects who have more than one wound that qualifies for the study.
In the Study, eligible Subjects will undergo the laceration repair procedure as is standard and customary for each Provider except for skin closure will be performed using microMend devices. If more than one device is needed, the devices are to be applied adjacent to one another along the entire length of the wound. microMend devices are to be applied immediately adjacent to one another with no more than 1 mm separating each adjacent device. (Note: Each device closes 1-1.5 cm of wound length.). In addition, devices should be applied such that they extend to or beyond the ends of the wound along its length.
A minimum of two (2) photographs will be taken of each wound both before and after the application of microMend devices on the day of the wound closure procedure (Day 0).
If a wound is under high tension and/or has a maximum gap of more than 1 cm between the wound edges, it should be closed with subcutaneous sutures before applying microMend devices. If this is not performed, the wound should not be closed with microMend and the Subject is not eligible for the study.
Standard surgical staples, sutures, tissue adhesives, SteriStrips or other bandages should not be used to close any portion of skin wounds closed with microMend devices.
Each wound should be free of significant tissue injury and bleeding, contain no foreign bodies, and should be clean and completely dry and free of hair before application of microMend.
No other wound closure products, such as tissue adhesives, bandages such as SteriStrips, staples, or sutures should be applied to the wound.
Solutions, ointments, creams, and other moist materials should be avoided during the time period when the microMend remains on the skin except those recommended by the Provider.
After application of the microMend devices, it is recommended that each wound be covered with a non-stick gauze dressing. (Note: contact of adhesive with microMend devices is strictly prohibited.) Subject contact with the wound site should be minimized after placement of the microMend devices and the dressing. All other activities associated with the laceration repair procedure should follow the standard procedure used by the Provider. The Provider will fill out a questionnaire about the wound closure procedure. The Subject will rate the level of pain associated with microMend application.
The microMend devices are to be removed at the return clinic visit on Day 10 (acceptable range: Days 7-12) by the Provider (Physician, Nurse Practitioner, Physician's Assistant, or other qualified health care provider). Photographs are to be obtained of each wound both before and after removal of all microMend devices. A minimum of two (2) photographs will be taken of each wound both before and after removal of microMend devices. The Subject will fill out a questionnaire providing an opinion of microMend.
Each Subject is to return to the clinic at one (1) month post-procedure (acceptable range: Days 25-40) to obtain photographs of each wound. A minimum of two (2) photographs will be taken at the 1-month clinic visit. Each Subject is to return to the clinic at three (3) months after wound closure (acceptable range: 11-15 weeks) to obtain photographs of each wound. A minimum of two (2) photographs will be taken at the 1-month clinic visit.
Photographs obtained on Day 0, Day 10, Month 1, and Month 3 will be assessed for wound closure results by an Independent Plastic Surgeon, who is not performing laceration repair or wound closure in the study. The wound closure will be rated as either Satisfactory or Unsatisfactory. The quality of the wound closure will further be rated as Excellent, Good, Fair, or Poor. For Subjects that have had more than one wound closed with microMend devices, each wound is to be assessed separately at Day 0, Day 10, Month 1, and Month 3.
Total duration of Subject participation will be approximately 4 months, including screening, treatment, and follow-up.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- A single arm open label study testing the ability of microMend to close lacerations.
| Arm | Type | Receives |
|---|---|---|
| Closure of lacerations with microMend | Experimental | Device: microMendLaceration closure with microMend |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Subjects undergoing a laceration repair that would require sutures, staples, or tissue adhesives to close the skin wound
- Age equal to or greater than 18 years old
- Written informed consent obtained from Subject or Subject's legal representative and ability for Subject to comply with the requirements of the Study
Key exclusion criteria (23 listed)
- Wound on face
- Wound on flexor surfaces such as over joints
- Wound on digits (fingers or toes)
- Wound under high tension, which is not closed with subcutaneous sutures before application of microMend devices
- Wound that has a gap of more than 1 cm between the wound edges immediately prior to application of microMend devices
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| microMendAlso: microMend Skin Closure DeviceWound closure product consisting of tan array of tiny metal Microstaples affixed to adhesive backing. The device is the size and shape of a butterfly closure and intended for closure of skin wounds. | Device | Closure of lacerations with microMend |
Primary outcome
Wound closure results of skin wounds after healing
Time frame: 3 months
Assessment of photographs of wounds closed with microMend at Monthg 3 by independent physician with experience in assessing skin wounds.
Overall assessment of microMend by Provider at end of the wound closure procedure.
Time frame: Day 0
Questionnaire on opinion of Provider (Physician, PA, or Nurse Practitioner on usability and other characteristics of microMend
Time of wound closure.
Time frame: ay 0
Measurement of time in seconds to close wound with microMend devices.
Subject's assessment of microMend.
Time frame: Day 0
Measurement of pain upon placement of microMend using VAS scoring system
Subject's assessment of pain with application of microMend
Time frame: Day 10
Questionnaire regarding evaluation of microMend
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Feb 2019.
- Derived from this study: PubMed 37220958Nizami T, Beaudoin F, Suner S, Aluisio A, Bhatt RA, Jay GD. Evaluation of microMend wound closure device in repairing skin lacerations. Emerg Med J. 2023 Aug;40(8):564-568. doi: 10.1136/emermed-2022-212667. Epub 2023 May 23.
- Individual participant dataSharing planned: No
Related trials for Lacerations
RecruitingObservational study
Validation of Interleukins and Other Cytokines Together With OCT Imaging for Rapid Infectious Keratitis Assessment
Keratitis Bacterial, Keratitis Fungal
Not yet recruiting
Voll Non-Degradable Shoulder Spacer FIH Study
Massive Rotator Cuff Tears, Massive Rotator Cuff Tear
Recruiting
Identification of Diagnosis Biomarkers in the Tears of Alzheimer's Disease Patients: The COG-EYE Pilot Study
Alzheimer Disease
Active, not recruiting
Clinical Trial on the Effect of REGENETEN Bioinductive Implant in the Supraspinatus Tendon Repair
Supraspinatus Tear
Not yet recruiting
Supporting Athletes' Return to Sports After ACL Reconstruction: A Study of a Psychological Readiness Program
Anterior Cruciate Ligament Reconstruction, Anterior Cruciate Ligament Injuries
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Francesca Beaudoin, MD, PhD principal investigator
Department of Emergency Medicine, Walpert School of Medicine, Brown University
Gregory Jay, MD, PhD principal investigator
Department of Emergency Medicine, Walpert School of Medicine, Brown University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing microMend in people with Lacerations and Wounds, run by KitoTech Medical, Inc. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 23 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 5 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Ronald Berenson, MD (206-790-1094, rberenson@kitotechmedical.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Wound closure results of skin wounds after healing (time frame: 3 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03830515, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Feb 2019.